
诺华 Novartis
诺华集团致力于为患者及社会提供创新医药健康解决方案,以满足其日益变化的健康需求。总部位于瑞士巴塞尔,诺华集团拥有多元化业务组合以最好地满足这些需求,包含创新药、成本节约型非专利药和生物类似药以及眼科保健产品。诺华在上述各领域均处于全球领先地位。2017年,集团净销售额达491亿美元,集团研发投入约为90亿美元。诺华集团拥有近12.5万名全职员工。诺华的产品在全球155个国家和地区销售。
Add to FavoritesPharmaceutical, biotech, and medical device companies worldwide choose to partner with MedSci because we understand the global medical communications landscape and have a proven record in the successful dissemination of technically rigorous and compliant scientific documents. MedSci believes in helping its customers scale the farthest reach of their vision by equipping them with therapeutic expertise and integrated software to translate scientific evidence into commercial success.
In keeping with its mission of advancing global science ethically, MedSci empowers its team of scientific experts through rigorous training and education on good publication practice and industry standards. This means that our customers will find a trusted advisor in any of our 80+ medical communication experts spread across offices in the China.
An effective, well-constructed publication plan provides the ultimate foundation for disseminating educational therapeutic information to healthcare providers and decision makers throughout a product's lifecycle.We are committed to ethical practices in publication development and have established an internal Publication Compliance Program. All employees are trained in and adhere to the guidelines that drive our industry, including the guidelines of the International Committee of Medical Journal Editors (ICMJE) and Good Publication Practice for Communicating Company-Sponsored Medical Research (GPP3)..
诺华集团致力于为患者及社会提供创新医药健康解决方案,以满足其日益变化的健康需求。总部位于瑞士巴塞尔,诺华集团拥有多元化业务组合以最好地满足这些需求,包含创新药、成本节约型非专利药和生物类似药以及眼科保健产品。诺华在上述各领域均处于全球领先地位。2017年,集团净销售额达491亿美元,集团研发投入约为90亿美元。诺华集团拥有近12.5万名全职员工。诺华的产品在全球155个国家和地区销售。
Add to Favorites